Introduction
Cardiac surgery today, while advanced, relies on separate tools for visualizing anatomy and measuring blood flow. Correlating information between multiple devices like this leaves room for uncertainty. Envision an innovative instrument seamlessly integrating Transit Time Flow Measurement (TTFM) with high-resolution imaging, transforming cardiac procedures by offering enhanced precision and real-time insights. The MiraQ enables surgeons to perform with accuracy, ultimately leading to improved patient outcomes.
MiraQ is the only instrument combining Transit Time Flow Measurement (TTFM) and high-resolution imaging. It empowers cardiac surgeons with precision and real-time insights, elevating patient outcomes in one innovative solution. Perform cardiac imaging, measure blood flow and receive immediate feedback on how well a graft is functioning.
Intraoperative surgical guidance and quality assessment with ultrasonic imaging and blood flow measurement:
- reduces risk of stroke for the patient.
- provides surgeons with a tool to verify graft functionality, revise when needed and optimize the graft strategy during surgery.
These benefits are displayed in the largest multi-center study to combine TTFM and High Frequency Ultrasound Imaging - the REQUEST Study.
The REQUEST Study
Global approach
Seven leading cardiac surgery centers from Europe, USA and Canada participated. The study was initially led by Professor Pieter Kappetein of Thorax Erasmus MC, Rotterdam, and later by Coordinating Investigator Professor David Taggart from the University of Oxford.
Inclusion criteria was isolated CABG with a minimum of two grafts. Medistim’s VeriQC™ or MiraQ™ devices were used.